Literature DB >> 28652204

Evidence for a Role of Nerve Injury in Painful Intervertebral Disc Degeneration: A Cross-Sectional Proteomic Analysis of Human Cerebrospinal Fluid.

Tony K Y Lim1, Kathleen M Anderson2, Pawan Hari3, Marcos Di Falco4, Troy E Reihsen5, George L Wilcox6, Kumar G Belani5, Sylvie LaBoissiere4, Manuel R Pinto7, David S Beebe5, Lois J Kehl8, Laura S Stone9.   

Abstract

Intervertebral disc degeneration (DD) is a cause of low back pain (LBP) in some individuals. However, although >30% of adults have DD, LBP only develops in a subset of individuals. To gain insight into the mechanisms underlying nonpainful versus painful DD, human cerebrospinal fluid (CSF) was examined using differential expression shotgun proteomic techniques comparing healthy control participants, subjects with nonpainful DD, and patients with painful DD scheduled for spinal fusion surgery. Eighty-eight proteins were detected, 27 of which were differentially expressed. Proteins associated with DD tended to be related to inflammation (eg, cystatin C) regardless of pain status. In contrast, most differentially expressed proteins in DD-associated chronic LBP patients were linked to nerve injury (eg, hemopexin). Cystatin C and hemopexin were selected for further examination using enzyme-linked immunosorbent assay in a larger cohort. While cystatin C correlated with DD severity but not pain or disability, hemopexin correlated with pain intensity, physical disability, and DD severity. This study shows that CSF can be used to study mechanisms underlying painful DD in humans, and suggests that while painful DD is associated with nerve injury, inflammation itself is not sufficient to develop LBP. PERSPECTIVE: CSF was examined for differential protein expression in healthy control participants, pain-free adults with asymptomatic intervertebral DD, and LBP patients with painful intervertebral DD. While DD was related to inflammation regardless of pain status, painful degeneration was associated with markers linked to nerve injury.
Copyright © 2017 American Pain Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Proteomics; cystatin C; hemopexin; intervertebral disc degeneration; low back pain

Mesh:

Substances:

Year:  2017        PMID: 28652204      PMCID: PMC5614853          DOI: 10.1016/j.jpain.2017.06.002

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  120 in total

1.  Changes in expression and localization of hemopexin and its transcripts in injured nervous system: a comparison of central and peripheral tissues.

Authors:  L Camborieux; N Bertrand; J P Swerts
Journal:  Neuroscience       Date:  1998-02       Impact factor: 3.590

2.  Abnormal magnetic-resonance scans of the lumbar spine in asymptomatic subjects. A prospective investigation.

Authors:  S D Boden; D O Davis; T S Dina; N J Patronas; S W Wiesel
Journal:  J Bone Joint Surg Am       Date:  1990-03       Impact factor: 5.284

3.  Long-lasting accumulation of hemopexin in permanently transected peripheral nerves and its down-regulation during regeneration.

Authors:  N Madore; Y Sagot; M J Guinaudy; P Cochard; J P Swerts
Journal:  J Neurosci Res       Date:  1994-10-01       Impact factor: 4.164

4.  Inflammation and reduced albumin synthesis associated with stable decline in serum albumin in hemodialysis patients.

Authors:  George A Kaysen; Joel A Dubin; Hans-Georg Müller; Laura Rosales; Nathan W Levin; William E Mitch
Journal:  Kidney Int       Date:  2004-04       Impact factor: 10.612

5.  Hematopoietic prostaglandin D2 synthase controls the onset and resolution of acute inflammation through PGD2 and 15-deoxyDelta12 14 PGJ2.

Authors:  Ravindra Rajakariar; Mark Hilliard; Toby Lawrence; Seema Trivedi; Paul Colville-Nash; Geoff Bellingan; Desmond Fitzgerald; Muhammad M Yaqoob; Derek W Gilroy
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-05       Impact factor: 11.205

6.  Proteomics-derived cerebrospinal fluid markers of autopsy-confirmed Alzheimer's disease.

Authors:  Alex E Roher; Chera L Maarouf; Lucia I Sue; Yiran Hu; Jeffrey Wilson; Thomas G Beach
Journal:  Biomarkers       Date:  2009-11       Impact factor: 2.658

7.  Prognostic factors after resection of pancreatic cancer.

Authors:  Michio Ueda; Itaru Endo; Masayuki Nakashima; Yuta Minami; Kazuhisa Takeda; Kenichi Matsuo; Yasuhiko Nagano; Kuniya Tanaka; Yasushi Ichikawa; Shinji Togo; Chikara Kunisaki; Hiroshi Shimada
Journal:  World J Surg       Date:  2009-01       Impact factor: 3.352

Review 8.  Pharmacotherapy of chronic pain: a synthesis of recommendations from systematic reviews.

Authors:  Kurt Kroenke; Erin E Krebs; Matthew J Bair
Journal:  Gen Hosp Psychiatry       Date:  2009-03-04       Impact factor: 3.238

9.  Disrupted TH17/Treg balance in patients with chronic low back pain.

Authors:  Benjamin Luchting; Banafscheh Rachinger-Adam; Julia Zeitler; Lisa Egenberger; Patrick Möhnle; Simone Kreth; Shahnaz Christina Azad
Journal:  PLoS One       Date:  2014-08-14       Impact factor: 3.240

10.  A Multiplex Protein Panel Applied to Cerebrospinal Fluid Reveals Three New Biomarker Candidates in ALS but None in Neuropathic Pain Patients.

Authors:  Anne-Li Lind; Di Wu; Eva Freyhult; Constantin Bodolea; Titti Ekegren; Anders Larsson; Mats G Gustafsson; Lenka Katila; Jonas Bergquist; Torsten Gordh; Ulf Landegren; Masood Kamali-Moghaddam
Journal:  PLoS One       Date:  2016-02-25       Impact factor: 3.240

View more
  5 in total

1.  Longitudinal CSF Iron Pathway Proteins in Posthemorrhagic Hydrocephalus: Associations with Ventricle Size and Neurodevelopmental Outcomes.

Authors:  Jennifer M Strahle; Kelly B Mahaney; Diego M Morales; Chandana Buddhala; Chevis N Shannon; John C Wellons; Abhaya V Kulkarni; Hailey Jensen; Ron W Reeder; Richard Holubkov; Jay K Riva-Cambrin; William E Whitehead; Curtis J Rozzelle; Mandeep Tamber; Ian F Pollack; Robert P Naftel; John R W Kestle; David D Limbrick
Journal:  Ann Neurol       Date:  2021-06-25       Impact factor: 11.274

2.  Interleukin-8 as a therapeutic target for chronic low back pain: Upregulation in human cerebrospinal fluid and pre-clinical validation with chronic reparixin in the SPARC-null mouse model.

Authors:  Emerson Krock; Magali Millecamps; Kathleen M Anderson; Akanksha Srivastava; Troy E Reihsen; Pawan Hari; Yue Ran Sun; Seon Ho Jang; George L Wilcox; Kumar G Belani; David S Beebe; Jean Ouellet; Manuel R Pinto; Lois J Kehl; Lisbet Haglund; Laura S Stone
Journal:  EBioMedicine       Date:  2019-04-30       Impact factor: 8.143

3.  Mass spectrometry-based analysis of cerebrospinal fluid from arthritis patients-immune-related candidate proteins affected by TNF blocking treatment.

Authors:  Johanna Estelius; Johan Lengqvist; Elena Ossipova; Helena Idborg; Erwan Le Maître; Magnus L A Andersson; Lou Brundin; Mohsen Khademi; Elisabet Svenungsson; Per-Johan Jakobsson; Jon Lampa
Journal:  Arthritis Res Ther       Date:  2019-02-15       Impact factor: 5.156

4.  CSF levels of apolipoprotein C1 and autotaxin found to associate with neuropathic pain and fibromyalgia.

Authors:  Anne-Li Lind; David Just; Maria Mikus; Claudia Fredolini; Marina Ioannou; Björn Gerdle; Bijar Ghafouri; Emmanuel Bäckryd; Lars Tanum; Torsten Gordh; Anna Månberg
Journal:  J Pain Res       Date:  2019-10-15       Impact factor: 3.133

Review 5.  Peripheral and Central Pathological Mechanisms of Chronic Low Back Pain: A Narrative Review.

Authors:  Wei Li; Yinan Gong; Jingyi Liu; Yongming Guo; Huiling Tang; Siru Qin; Yadan Zhao; Songtao Wang; Zhifang Xu; Bo Chen
Journal:  J Pain Res       Date:  2021-05-27       Impact factor: 3.133

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.